Health Canada
- Status: approved
Reversal of moderate neuromuscular blockade (Reversal of moderate neuromuscular blockade) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
Pontificia Universidade Catolica de Sao Paulo is the originator. The local marketing authorisation holder may differ — check the official source linked above.